English | Español
Bree Gonzales | Aug 28, 2021

Pfizer’s is the first FDA-approved coronavirus vaccine, and now it has a name: Comirnaty

Press release submission | Aug 28, 2021

Doctors are using VREasyWait to introduce themselves to their patients
Press release submission | Aug 27, 2021

GUIDE-HF Study Data Show Abbott's CardioMEMS™ Device Can Improve Care for More Patients with Heart Failure
Press release submission | Aug 27, 2021

Laekna Therapeutics Receives IND Approvals in China and US for Phase Ib/III Global Multi-center Clinical Study of Afuresertib in combination with fulvestrant for patients with HR+/HER2- breast cancer
Press release submission | Aug 27, 2021

Airway Therapeutics Announces First Patient Dosed in Phase 1b Trial of AT-100 in Severe COVID-19 Patients
Press release submission | Aug 26, 2021

Northern California Patients Now Have Access to Noninvasive Varian Edge Cancer Treatment
Bree Gonzales | Aug 25, 2021

Discovery Behavioral Health acquires treatment center for 'increasingly challenging health environment'
Bree Gonzales | Aug 25, 2021

Surge in PTSD risk for Americans: “It is beginning to feel like we are back where we started'

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access